Director Ezra Uzi Yemin reports Form 144 sale

Ezra Uzi Yemin and affiliated Yemin Investments LP reported sales of Common stock.

Rhea-AI Filing Summary

Ezra Uzi Yemin and affiliated Yemin Investments LP reported sales of Common stock. The filing shows Yemin Investments LP sold 66,511 shares on 03/04/2026 and Ezra Uzi Yemin sold 18,139 shares on 03/04/2026. The transactions are reported on a Form 144 as transfers of previously acquired compensation shares.

Insights

Insider Transactions Analyst

Routine Form 144 disclosure of insider share dispositions by Ezra Uzi Yemin and an affiliated LP.

The filing lists specific dispositions: 66,511 shares by Yemin Investments LP and 18,139 shares by Ezra Uzi Yemin, both dated 03/04/2026. These are reported transfers of previously acquired compensation shares.

Cash‑flow treatment and remaining post‑transaction holdings are not stated in the excerpt; subsequent filings or market reports would be needed for position context.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ezra Uzi Yemin report in the Form 144 for DK?

The filing reports sales of Common stock by Ezra Uzi Yemin and an affiliated LP on 03/04/2026. Specifically, it lists 66,511 shares sold by Yemin Investments LP and 18,139 shares sold by Ezra Uzi Yemin on that date.

How many shares did Yemin Investments LP sell according to the Form 144?

Yemin Investments LP sold 66,511 shares of Common stock on 03/04/2026. The filing characterizes these as transfers of shares originally acquired as compensation on earlier grant dates.

Are the sold shares described as compensation shares in the filing?

Yes. The transactions are described as transfers of shares that Ezra Uzi Yemin acquired via compensation on various prior dates. The Form 144 lists original acquisition dates alongside the transfers.

Does the Form 144 state how much cash was received from the sales?

The excerpt does not provide cash proceeds or prices for the transactions. The filing lists share quantities and transfer dates but does not disclose sale prices or aggregate proceeds.

Which dates show prior compensation acquisitions listed in the filing?

The filing lists multiple prior acquisition dates, including 08/07/2012, 12/09/2016, 01/24/2017, 03/10/2016, 06/10/2017, 09/10/2017, and 12/10/2017 as acquisition origins for transferred shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001361091
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Delek US Holdings , Inc.
SEC File Number	001-38142
Address of Issuer	310 Seven Springs Way Suite 500 Brentwood TENNESSEE 37027
Phone	6157716701
Name of Person for Whose Account the Securities are To Be Sold	Ezra Uzi Yemin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	161764	6849087	59807421	03/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2019	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 03/10/2016	Ezra Uzi Yemin			86352	03/09/2019	NA
Common	12/10/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 12/10/2017	Ezra Uzi Yemin			12102	12/10/2017	NA
Common	06/10/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 06/10/2017	Ezra Uzi Yemin			11485	06/10/2017	NA
Common	09/10/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 09/10/2017	Ezra Uzi Yemin			61	09/10/2017	NA
Common	09/10/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 09/10/2017	Ezra Uzi Yemin			2463	09/10/2017	NA
Common	09/10/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 09/10/2017	Ezra Uzi Yemin			5943	09/10/2017	NA
Common	09/10/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 09/10/2017	Ezra Uzi Yemin			7600	09/10/2017	NA
Common	12/09/2016	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 12/09/2016	Ezra Uzi Yemin			2017	12/09/2016	NA
Common	12/09/2016	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 12/09/2016	Ezra Uzi Yemin			2411	12/09/2016	NA
Common	12/09/2016	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 12/09/2016	Ezra Uzi Yemin			4749	12/09/2016	NA
Common	01/24/2017	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 01/24/2017	Ezra Uzi Yemin			14503	01/24/2017	NA
Common	08/07/2012	Transfer - Ezra Uzi Yemin who acquired the shares via Compensation on 08/07/2012	Ezra Uzi Yemin			12078	08/07/2012	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Yemin Investments LP 310 SEVEN SPRINGS WAY Suite 500 Brentwood TN 37027	Common	03/04/2026	66511	2871419
Ezra Uzi Yemin 310 SEVEN SPRINGS WAY Suite 500 Brentwood TN 37027	Common	03/04/2026	18139	783098

144: Remarks and Signature

Remarks	The shares filed today will be sold by Yemin Investments LP, Ezra Uzi Yemin as Trustee/General Partner.
Date of Notice	03/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Ezra Uzi Yemin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)